Semis just failed to complete a top relative to the broader market and are now reasserting their leadership.
If this risk-on group is in good shape, then stocks are likely to perform well in the future. So this is a positive development from a broader market perspective.
So today's trade is in a lesser known semiconductor name that is atop the relative strength leaderboard.
Today's trade is in a name that specializes in 3D geolocation technology, offering positioning, navigation, and timing (PNT) solutions—especially in situations where traditional GPS fails.
And I think it's got all-time highs in it's sights.
Today's trade is in a $29B ultra-processed packaged foods giant that has been struggling since 2023 and feels like its hanging on the precipice of a deeper fall.
Whether or not that comes to pass, this stock feels like a good place to put on a slightly bearish bet to give my bullish portfolio a bit of diversification in case the broader market stalls here.
Today's trade is in a stock that has been seemingly left for dead. Which is ironic, considering this company is engaged in keeping people alive.
This biotech company is an astounding 95% off it's 2021 highs.
But here's the thing... this stock just crossed above its 50-day moving average and appears to be holding there. And with a new leg higher in the stock market likely to lift a lot of boats, there is opportunity here.
Back in early April, I made a bet that silver would play catch-up to the vastly outperforming gold complex utilizing an options trader's version of a pairs trade. You can read about it here.
Both instruments had a bit of a wild ride following the "Liberation Day" Luau, especially SLV. But thanks to the somewhat offsetting risks of the short-biased GLD trade, we road out the volatility admirably.
Today, following SLV's recent run and dramatic outperformance against GLD, I think now is the time to take our profits.
Today's trade is in a silver miner that has already had a great run, but could surprise everyone by further doubling from here.
Buying after a big run is always hard, psychologically, and today is no different. So I'm going to take some of the sting out of the purchase with a creative spread and aggressive rolling strategy.
Today's trade is in a biotech stock. And the word "biotech" should cue thoughts of "risky" and "volatile."
And this trade is no exception. So I'm going to get creative, utilizing a spread to lower my cost of participation, define my risk, and give me two paths to profitability.
I love finding stocks that are under the radar, but are starting to get noticed, quietly. That's what my team's Under the Hood report uncovers, and today's trade comes from the most recent release.
We're getting involved early, before the masses catch on and send this stock back to yearly highs, which would be a nice ride from here.
Last week, I got involved in Coinbase as a play on a new alt-season being on the cusp of breaking out. But Coinbase isn't the only brokerage with a chart that looks great.
Another one broke out to a post-IPO high today and I'm getting involved to broaden my exposure to this space.
More and more stocks are flirting with all time highs. Today's trade has all-timers in sight, as well as a possible Hundred-dolla-roll -- two things that make me incredibly bullish.
With Bitcoin holding high in the 107-108K neighborhood, above last year's resistance, it feels like the stage is being set for another crypto bull. Not just for bitcoin, but for many of the so-called "alt-coins" as well. And today's trade is in the company that is best positioned to take advantage of a resurgence of alt-coin activity.
And following a recent gap move higher, the consolidation over the past couple weeks and today's morning dip provide a great entry point.